Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04732624Phase 3Completed
Phase 3, randomised, open-label trial of low osmolar oral rehydration salts in burn injury (2 arms), sponsored by University of Washington. Primary endpoints: 24 Hour Average Urine Output, 24-hour Resuscitation Volume and 1 more. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04732624.